Skip to main content
. Author manuscript; available in PMC: 2007 Aug 21.
Published in final edited form as: Int J Cancer. 2006 Mar 1;118(5):1234–1240. doi: 10.1002/ijc.21474

Figure 2.

Figure 2

Kaplan-Meier estimates of recurrence-free probability according to pretreatment hK2 levels. Recurrence-free probabilities for patients with pre-treatment hK2 levels below (solid line) and above (dashed line) the median of 0.091 ng/ml within the whole cohort (n = 461).